Department of Midwifery, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Department of Reproductive Health and Population Studies, School of Public Health, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
BMC Womens Health. 2023 Apr 11;23(1):175. doi: 10.1186/s12905-023-02331-1.
Pregnant mothers are a risky population group for COVID-19 and pregnant mothers with COVID-19 are at increased risk of hospitalization, intensive-care unit admission, invasive ventilation support, and maternal mortality. Vaccination is an essential tool in stopping the effect of the pandemic on maternal and child health. However, there are only limited studies in Ethiopia on the intention to take the COVID-19 vaccine among pregnant women. Thus, this study aimed to assess intention to take the COVID-19 vaccine and associated factors among pregnant women in Bahir Dar city, Northwest Ethiopia.
Facility based cross-sectional study was conducted among 590 pregnant women from 23 May to 07 July 2022. The study participants were selected using a systematic sampling technique. Interviewer administrative questionnaire with epicollect5 application was used to collect the data. Both bi-variable and multivariable binary logistic regression analysis was performed. Statistical significance was defined at a 95% CI with a p-value < 0.05.
Overall, 19.8% (95% CI: 16.60-23.06%) of pregnant women intend to take the COVID-19 vaccine. Being urban residence (AOR = 3.40, 95% CI: 1.71-6.78), third trimester of gestational age (AOR = 3.11, 95% CI: 1.61-6.03), multipara (AOR = 2.30, 95% CI: 1.33-3.97), knowledge of COVID-19 vaccine (AOR = 2.33, 95% CI: 1.44-3.77) and having good attitude towards COVID-19 vaccine (AOR = 2.68, 95% CI: 1.65-4.33) were significantly associated with intention to take COVID-19 vaccine.
In conclusion, the pregnant women's intention to take the COVID-19 vaccine in this study area was very low. It was significantly associated with residency, gestational age, parity, knowledge, and attitude toward the vaccine. Therefore, strengthening interventions that improve knowledge and attitude about the COVID-19 vaccine, predominantly among those primipara mothers and mothers from rural residences, may raise the intention to take it.
孕妇是 COVID-19 的高危人群,而感染 COVID-19 的孕妇住院、入住重症监护病房、接受有创通气支持和母婴死亡的风险增加。疫苗接种是阻止大流行对母婴健康影响的重要工具。然而,在埃塞俄比亚,只有有限的研究关注孕妇接种 COVID-19 疫苗的意愿。因此,本研究旨在评估巴希尔达尔市孕妇接种 COVID-19 疫苗的意愿及其相关因素。
2022 年 5 月 23 日至 7 月 7 日,采用基于设施的横断面研究,对 590 名孕妇进行了研究。研究参与者采用系统抽样技术进行选择。使用带有 epicollect5 应用程序的访谈员行政问卷收集数据。进行了单变量和多变量二元逻辑回归分析。统计显著性定义为 95%置信区间的 p 值<0.05。
总体而言,19.8%(95%置信区间:16.60-23.06%)的孕妇表示打算接种 COVID-19 疫苗。城市居住(AOR=3.40,95%置信区间:1.71-6.78)、妊娠晚期(AOR=3.11,95%置信区间:1.61-6.03)、多产妇(AOR=2.30,95%置信区间:1.33-3.97)、对 COVID-19 疫苗的了解(AOR=2.33,95%置信区间:1.44-3.77)和对 COVID-19 疫苗的良好态度(AOR=2.68,95%置信区间:1.65-4.33)与接种 COVID-19 疫苗的意愿显著相关。
综上所述,本研究地区孕妇接种 COVID-19 疫苗的意愿非常低。它与居住地、孕龄、产次、知识和对疫苗的态度显著相关。因此,加强针对 COVID-19 疫苗的知识和态度的干预措施,主要针对初产妇和农村地区的母亲,可能会提高接种意愿。